TMS Therapy Cost: What to Expect and Insurance Coverage

A full course of TMS therapy (transcranial magnetic stimulation) costs $6,000 to $15,000 without insurance, or about $200 to $400 per session across the standard 36 sessions. Most commercial plans and Medicare cover TMS for treatment-resistant depression after prior authorization, which brings typical out-of-pocket costs down to $900 to $2,700 in copays, and you can recover more of what you pay through appeals, out-of-network reimbursement and HSA or FSA funds.

TMS is a noninvasive outpatient treatment, so the cost of recovery itself is close to zero: there is no anesthesia, no hospital stay and no downtime after a session. The real cost questions are the price of the course, what your plan will pay, and how to get money back when it pays less than expected. Each one has its own section below, followed by a comparison with esketamine, ketamine, ECT and medication trials.

What TMS Costs: The Full Breakdown

Transcranial magnetic stimulation (TMS) pricing varies significantly by geographic location, provider type, protocol, and insurance coverage. The cost includes the sessions themselves, the initial evaluation, and sometimes neuroimaging or mapping fees.

TMS is also called repetitive transcranial magnetic stimulation (rTMS) in its standard form. Deep TMS (dTMS) uses an H-coil to reach broader and deeper brain regions, and intermittent theta-burst stimulation (iTBS) is a faster pattern delivered on the same machines. All three are priced per session, and the TMS treatment guide explains how each one works.

Standard Protocol Costs

The FDA-cleared standard protocol for depression involves 36 treatment sessions: 5 sessions per week for 6 weeks (30 sessions), followed by a 3-week taper of 2 sessions per week (6 additional sessions) [1].

The wide price range reflects geographic variation (urban centers cost more), provider overhead (hospital-based programs cost more than standalone clinics), and the specific TMS system used.

Accelerated/Intensive Protocol Costs

The Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) protocol, published in 2020 and now offered at select centers, delivers 10 sessions per day for 5 consecutive days (50 sessions total) using theta-burst stimulation (TBS) with neuroimaging-guided targeting [2].

Insurance coverage for accelerated protocols is less established than for standard TMS. Some insurers cover it as an equivalent to standard TMS; others consider it experimental. Check with your specific plan.

The SAINT trial by Cole and colleagues at Stanford was small and short, so the evidence for accelerated TMS is thinner than for the standard course [2]. Ask the clinic in writing whether your plan has approved the accelerated schedule before you pay a deposit, because a denial after treatment leaves the full amount with you.

Theta-Burst Stimulation (TBS)

Intermittent theta-burst stimulation (iTBS) was FDA-cleared in 2018 and delivers each session in approximately 3 minutes compared to 19-37 minutes for standard repetitive TMS. Session costs are similar ($200-$400), but the shorter session time makes it more practical for patients with scheduling constraints.

Shorter sessions mean less time away from work and fewer hours of childcare or parking, which are real costs that never appear on the clinic invoice. The post on theta-burst stimulation as a faster TMS protocol covers the trade-offs in more detail.

Insurance Coverage: What to Expect

Commercial Insurance

The majority of major commercial insurers now cover TMS for treatment-resistant depression. Coverage typically requires [3]:

1. Diagnosis: Major depressive disorder (MDD), moderate to severe
2. Treatment resistance: Documented failure of at least 2 adequate antidepressant trials (adequate = appropriate dose for at least 6-8 weeks each). Some plans require 3-4 failures.
3. Prior authorization: Required by most plans. The TMS provider typically handles this.
4. PHQ-9 documentation: Baseline depression severity score on a validated scale.

Insurers that generally cover TMS (verify with your specific plan):

• Blue Cross Blue Shield (most plans)
• Aetna
• Cigna
• UnitedHealthcare
• Humana
• Kaiser Permanente (select regions)

Common denial reasons and how to address them:

• “Not medically necessary”: Appeal with documentation of medication failures and current symptom severity.
• “Experimental/investigational”: Cite FDA clearance (2008 for NeuroStar, 2013 for Brainsway, 2018 for iTBS) and APA guideline recommendations.
• “Insufficient medication trials”: Ensure each failed trial is documented with dose, duration, and reason for discontinuation.

Coverage is written for depression. TMS also has FDA clearances for obsessive-compulsive disorder (OCD), smoking cessation and migraine, but insurers cover those uses far less often, so patients seeking OCD treatment with TMS should expect to make a stronger case or pay cash. Off-label uses, such as TMS for anxiety, PTSD or addiction, are usually self-pay.

Medicare

Medicare Part B covers TMS for treatment-resistant MDD as an outpatient service, under Local Coverage Determinations (LCDs) published by regional Medicare Administrative Contractors. Requirements:

• Diagnosis of MDD
• Failure of at least 1 adequate antidepressant trial in the current episode (stricter plans require 2)
• Prior authorization from the Medicare Administrative Contractor (MAC)
• Treatment by a physician or qualified practitioner

Medicare Advantage plans may have additional requirements. Medigap supplemental policies cover the remaining 20% coinsurance after Medicare pays its 80%.

Medicaid

Medicaid coverage for TMS varies significantly by state. Some state Medicaid programs cover TMS; others do not. Check with your state’s Medicaid program directly.

VA (Veterans Affairs)

The VA covers TMS at its medical centers for veterans with treatment-resistant depression. Access depends on facility availability, as not all VA centers have TMS equipment.

Billing codes your claim will use

TMS claims are billed with three CPT codes: 90867 for the first session with motor threshold mapping, 90868 for each later treatment session, and 90869 when the motor threshold is measured again during the course. Knowing these codes lets you ask your insurer for the exact allowed amount per code before treatment starts, which is the most reliable way to estimate your share of the bill.

How TMS Cost Recovery Works: Getting Money Back After You Pay

TMS cost recovery means getting part of what you paid for a TMS course back from your insurer, your tax-advantaged accounts or the clinic. Patients usually recover costs through four routes: an insurance appeal after a denial, out-of-network reimbursement with a superbill, HSA or FSA reimbursement, and a corrected bill when a session was coded or priced wrong.

1. Appeal a denied claim. Ask the clinic for the denial letter, then file an internal appeal with your medication history, PHQ-9 scores and a letter of medical necessity from the prescribing psychiatrist. If the internal appeal fails, most plans must offer an external review by an independent reviewer.
2. Submit a superbill for out-of-network care. If your clinic is out of network, ask for a superbill that lists the CPT codes, diagnosis code, dates of service and amounts paid. Plans with out-of-network benefits reimburse a share of the allowed amount after your deductible.
3. Reimburse yourself from an HSA or FSA. TMS for a diagnosed condition is a qualified medical expense under IRS Publication 502, so you can pay with the account card or reimburse yourself later with itemized receipts.
4. Check every statement. Compare the explanation of benefits (EOB) for each session with the clinic invoice. Duplicate sessions, a mapping code billed twice, or copays charged after you met your out-of-pocket maximum are common billing errors that clinics refund on request.

Keep copies of every receipt, EOB and authorization letter from the first evaluation onward. Recovery requests that arrive months later succeed far more often when the paperwork is complete.

Is there a recovery period that adds to the cost?

TMS has no recovery period. Patients stay awake, need no sedation, and usually drive themselves home and return to work the same day, so there are no hidden costs for a companion, time off after sessions or an overnight stay. The common side effects are scalp discomfort and headache during the first sessions, and seizures are rare.

How TMS Compares Cost-Wise

Context matters when evaluating TMS cost. Consider the alternatives for treatment-resistant depression:

A 2019 cost-effectiveness analysis by Voigt, Carpenter and Leuchter found that TMS was cost-effective compared to continued medication management for treatment-resistant depression, with an incremental cost-effectiveness ratio well below the $50,000/QALY threshold used in US health economics [4].

The figures in the table come from different studies and patient groups, so they show rough cost and response ranges rather than a head-to-head result. ECT carries anesthesia and memory side effects that TMS does not, and IV ketamine for depression is off label and almost always cash pay. The posts comparing TMS and ECT, TMS and ketamine and the cost of ketamine therapy walk through each option in detail.

Reducing Out-of-Pocket Costs

1. Use an in-network provider. TMS at an out-of-network clinic may have significantly higher out-of-pocket costs even with insurance.
2. Ask about payment plans. Many TMS providers offer interest-free payment plans spreading the cost over 6-12 months.
3. Use your HSA/FSA. TMS is a qualified medical expense for Health Savings Accounts and Flexible Spending Accounts.
4. Appeal denials. First-time insurance denials are common. Peer-to-peer reviews (where your provider speaks directly with the insurance medical director) have high overturn rates.
5. Ask about clinical trials. Academic medical centers sometimes offer TMS for free through research protocols. ClinicalTrials.gov lists active studies.
6. Compare hospital vs. standalone clinics. Hospital-based TMS programs often charge facility fees that inflate the total cost. Standalone TMS clinics may offer the same treatment at 30-50% lower cost.
7. Check manufacturer assistance programs. NeuroStar and Brainsway offer patient assistance resources through their websites.

Timing matters too. Starting a course early in your plan year can mean you meet the deductible and out-of-pocket maximum within a single year, while a course split across two plan years can mean paying the deductible twice.

What Affects the Final Price

• Number of sessions: Standard protocol is 36, but some patients need fewer (if responding quickly) or more (if partial response warrants extension).
• Protocol type: Standard rTMS vs. theta-burst (iTBS) vs. deep TMS (Brainsway). Session duration varies but per-session cost is similar.
• Geographic location: Major metropolitan areas (NYC, LA, SF) have higher per-session rates than smaller cities.
• Maintenance sessions: Some patients need periodic maintenance sessions (monthly or quarterly) to sustain remission. Budget $200-$400 per maintenance session.
• Add-on neuroimaging: MRI-guided targeting (used in some accelerated protocols) adds $500-$2,000 to total cost.
• Who runs the sessions: A psychiatrist prescribes the course and sets the target, while trained TMS technicians usually deliver daily sessions under supervision. Programs where a physician sees you more often may bill more evaluation visits.

Is TMS Worth the Investment?

For patients with treatment-resistant depression, the question is not just financial. Depression that does not respond to medications costs far more than TMS in lost productivity, emergency visits, hospitalizations, and quality of life [5]. Greenberg and colleagues (2021) estimated the economic burden of adult major depressive disorder in the United States at $326.2 billion in 2018, with most of it falling on workplace costs rather than treatment.

The response rates are meaningful: roughly half of patients who have failed 2+ medications respond to TMS. One-third achieve remission. For patients who do respond, the effects of a single treatment course last 6-12 months on average, with some patients maintaining benefit for years.

Those practice figures are higher than the rates in the sham-controlled trials that led to FDA clearance, including the O’Reardon (2007) industry trial and the NIH-funded trial by George and colleagues (2010), where remission was more modest [1] [6]. The honest reading is that TMS helps a meaningful share of people with treatment-resistant depression, not most of them, and no clinic can tell you in advance whether you will respond.

A single course of TMS may be the most cost-effective step in a treatment-resistant depression journey, especially compared to years of trial-and-error medication changes with their associated side effects, provider visits, and functional impairment. The depression treatment guide sets TMS alongside the other options a psychiatrist may suggest.

Questions to Ask Your TMS Provider

• What is your per-session rate and total course estimate?
• Do you handle insurance prior authorization?
• What is your typical insurance approval rate?
• Do you offer payment plans?
• Which TMS system do you use (NeuroStar, Brainsway, MagVenture)?
• Do you offer both standard rTMS and theta-burst protocols?
• What is your response and remission rate in your patient population?
• How do you handle maintenance if I respond to the initial course?
• Will you provide a superbill with CPT codes if my plan treats you as out of network?
• What do I owe if my insurer denies coverage partway through the course?

Finding a TMS Clinic and Comparing Prices

The national directory of TMS clinics lists providers by state and city, so you can compare standalone clinics with hospital programs near you before you call for quotes. Regenerated.com is free for patients, and listing order on the clinic hub is not a paid ranking.

Featured slots are labeled and capped, so you can always tell a paid placement from an organic listing. Verified means the clinic completed claim and credential checks, not that it spent money. The guide to Featured, Verified and organic listings explains each label, and inclusion in the directory is not an endorsement of any clinic.

Related Reading

• TMS Therapy: The Evidence-Based Guide (Pillar)

Frequently Asked Questions

How much does TMS therapy cost without insurance?

A standard course of 36 TMS sessions costs $6,000 to $15,000 without insurance, which works out to about $200 to $400 per session. The initial psychiatric evaluation adds another $200 to $500. With insurance, out-of-pocket costs typically fall to $900 to $2,700 in copays, or roughly $25 to $75 per session as copay or coinsurance. Accelerated five-day protocols run $5,000 to $10,000, plus $500 to $2,000 when MRI targeting is required.

Does insurance cover TMS therapy?

Most major insurers cover TMS for treatment-resistant depression when three conditions are met: a diagnosis of moderate to severe major depressive disorder, failure of at least two adequate antidepressant trials, and prior authorization. Medicare Part B covers it under regional Local Coverage Determinations and can require only one failed trial in the current episode. Medicaid coverage varies by state, and the VA offers TMS at medical centers that have the equipment.

How many TMS sessions does a full course take?

The standard TMS course is 36 sessions over about nine weeks: five sessions per week for six weeks (30 sessions), followed by a three-week taper of two sessions per week. Each session of standard repetitive TMS runs about 19 to 37 minutes, while an iTBS (theta-burst) session takes approximately 3 minutes. The accelerated SAINT schedule compresses 50 shorter sessions into five days, with 10 sessions each day.

How effective is TMS therapy?

TMS produces a response in about 50 to 60 percent and remission in about 30 to 35 percent of patients with treatment-resistant major depressive disorder in clinical practice, according to data summarized by the Clinical TMS Society (Perera et al., 2016). Sham-controlled trials show more modest remission. For people who respond, benefits from one course last 6 to 12 months on average, and some need maintenance sessions to sustain them.

Are there ways to lower the cost of TMS?

Yes. Many providers offer interest-free payment plans spread over 6 to 12 months, and TMS is a qualified medical expense for HSAs and FSAs. NeuroStar and Brainsway offer patient assistance resources through their websites, and academic medical centers sometimes provide TMS for free through research protocols. Standalone TMS clinics may offer the same treatment at 30 to 50 percent lower cost than hospital-based programs, and in-network care avoids balance billing.

Is TMS therapy FDA approved?

TMS devices are FDA cleared rather than approved, which is the pathway the FDA uses for most medical devices. NeuroStar was cleared for depression in 2008, Brainsway deep TMS in 2013, and intermittent theta-burst stimulation in 2018. Insurers recognize these clearances for depression, so citing them is the standard response when a claim is denied as experimental or investigational. Uses outside the cleared indications are usually paid out of pocket.

Sources

1. O’Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208-1216. doi:10.1016/j.biopsych.2007.01.018 ↩
2. Cole EJ, Stimpson KH, Bentzley BS, et al. Stanford Accelerated Intelligent Neuromodulation Therapy for treatment-resistant depression. Am J Psychiatry. 2020;177(8):716-726. doi:10.1176/appi.ajp.2019.19070720 ↩
3. Perera T, George MS, Grammer G, et al. The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul. 2016;9(3):336-346. doi:10.1016/j.brs.2016.03.010 ↩
4. Voigt J, Carpenter L, Leuchter A. Cost effectiveness of high-dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression. J Affect Disord. 2019;249:383-392. doi:10.1016/j.jad.2019.02.047 ↩
5. Greenberg PE, Fournier AA, Sisitsky T, et al. The economic burden of adults with major depressive disorder in the United States (2010 and 2018). Pharmacoeconomics. 2021;39(6):653-665. doi:10.1007/s40273-021-01019-4 ↩
6. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67(5):507-516. doi:10.1001/archgenpsychiatry.2010.46 ↩